About Rashmi Pharma
Rashmi Pharma is a Healthcare company based in India founded in 1999. It manufactures ready-to-fill pellets for pharmaceutical formulations and applications. It operates on a B2B model. The company has 46 employees. Its Indian entity Rashmi Pharma Private Limited reported revenue of ₹18.17 Cr. Rashmi Pharma offers products and services including Immediate Release Pellets, Delayed Release Pellets, Sustained Release Pellets, Blended Pellets, and Nutraceuticals. Its focus areas include Pharmaceuticals, Nutraceuticals, Therapeutic Products and Manufacturing.
Company details
Rashmi Pharma is a manufacturer of semi-finished formulations in ready-to-fill pellets form for various therapeutic categories. Operating since 1999 in the Indian pharmaceutical market, they produce products like immediate release pellets and nutraceuticals. Based in Hyderabad, India, the company focuses on diverse applications including delayed and sustained release options, serving the pharmaceutical industry with a global presence through their portfolio.
- Headquarters India
- Employees 46
- SectorsHealthcare
- Email••••••••
- Website rashmipharma.net
- Legal Name Rashmi Pharma Private Limited
- Date of Incorporation 19 Apr, 1999
- Jurisdiction Telangana, India
- Annual Revenue₹18.17 Cr
FY 2025 · +22% YoY
- Net Profit₹37.3 Lakh
FY 2025 · 2% margin
- EBITDA₹1.78 Cr
FY 2025 · 10% margin
- Employee Count46
Associated legal entities of Rashmi Pharma
Rashmi Pharma operates through Rashmi Pharma Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2025) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Rashmi Pharma Private Limited CIN U24239TG1999PTC031538 | Active | 19 Apr 1999 | Hyderabad, Telangana | ₹18.2 Cr | 46 | 4 | View details |
Products & Services of Rashmi Pharma
Rashmi Pharma offers a comprehensive portfolio of products and services, including Immediate Release Pellets, Delayed Release Pellets, Sustained Release Pellets, Blended Pellets, and Nutraceuticals.
Pellets designed for immediate drug release in formulations
Enteric coated pellets for delayed drug release applications
Pellets providing extended drug release over time
Combination pellets for various therapeutic uses
Products blending nutrition and pharmaceuticals for health
Board of directors of Rashmi Pharma Private Limited (Rashmi Pharma)
Rashmi Pharma Private Limited is the primary company behind Rashmi Pharma. The board of Rashmi Pharma Private Limited currently have 4 directors; the longest-serving is Gundrati Jagannath, appointed in 1999. 3 earlier directors have ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Gundrati Jagannath DIN 01293930 | Managing Director | 19 Apr 1999 | 27 yrs 6 mo | Rashmi Pharma Private Limited |
| Gundrathi Prasuna DIN 02540804 | Whole-time director | 05 Aug 2019 | 7 yrs 2 mo | Rashmi Pharma Private Limited |
| Gundrathi Sai Rashmi DIN 10617167 | Director | 06 May 2024 | 2 yrs 5 mo | Rashmi Pharma Private Limited |
| Gundrati Naga Bharath DIN 07949283 | Director | 08 Aug 2024 | 2 yrs 2 mo | Rashmi Pharma Private Limited |
Financials of Rashmi Pharma
Figures of Rashmi Pharma Private Limited, the primary company behind Rashmi Pharma, for FY 2025. Revenue was ₹18.17 Cr (+22% year on year). Net profit was ₹37.3 Lakh (2% margin). EBITDA was ₹1.78 Cr (10% margin). Revenue has grown at a compounded annual rate of -3% over three years and -2% over five years.
- ₹18.17 CrRevenue · FY 2025 · +22% YoY
- ₹37.3 LakhNet profit · 2% margin
- ₹1.78 CrEBITDA · 10% margin
- ₹2.04 CrPaid-up capital
- 46Employees (provident fund records)
- -3%Revenue CAGR, 3 years
- -2%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Rashmi Pharma Private Limited are on its company page.
Detailed financial statements for Rashmi Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Rashmi Pharma
Rashmi Pharma was founded in 1999.
Rashmi Pharma is headquartered in India.
Rashmi Pharma has 46 employees.
The primary company behind Rashmi Pharma, Rashmi Pharma Private Limited, reported revenue of ₹18.17 Cr for FY 2025, up 22% year on year.
Rashmi Pharma is a manufacturer of semi-finished formulations in ready-to-fill pellets form for various therapeutic categories. Operating since 1999 in the Indian pharmaceutical market, they produce products like immediate release pellets and nutraceuticals. Based in Hyderabad, India, the company focuses on diverse applications including delayed and sustained release options, serving the pharmaceutical industry with a global presence through their portfolio.
Rashmi Pharma offers Immediate Release Pellets, Delayed Release Pellets, Sustained Release Pellets, Blended Pellets, and Nutraceuticals.
Rashmi Pharma operates through Rashmi Pharma Private Limited.
The legal entities of Rashmi Pharma currently have 4 directors, including Gundrati Naga Bharath, Gundrathi Sai Rashmi, Gundrathi Prasuna and others.